Risk factor
Very vulnerable to price shocks
Profitability factor
Solid dividends
About
Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It is also involved in the wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, and food and beverages; and the acquisition and rental of land for constructing buildings. In addition, the company invests in various industrial projects; and establishes, operates, and maintains commercial centers. It operates three hospitals under the Al Hammadi Hospital name in Olaya, Suwaidi, and Al Nuzha districts of Riyadh. The company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITD.
Target Price
The average target price of 4007.SR is 43 and suggests 64% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
